Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: GLAXOSMITHKLINE, LLC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2025-09-30 to 2026-09-29
Current total value of award: $9099990
Description: RELENZA (ZANAMIVIR) ROTADISK, 5MG